Boston Life deal

The Boston company signed a letter of intent with Children's Hospital of Boston to acquire exclusive worldwide rights to Axogenesis Factor 1, a recently discovered central nervous system growth factor. AF-1 acts specifically on nerve cells to promote the growth of their axons. ...